The global proteinase K market size is predicted to reach US$ 107.5 Million by 2027 according to a new study by Polaris Market Research. The report “Proteinase K Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Infectious diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Neurology, and Others); By Form (Powder, and Liquid), By Regions; Segment Forecast, 2020 - 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global proteinase K demand is anticipated to grow owing to the increasing prevalence of COVID-19 cases, establishment of universities and government-funded laboratories, population-based studies, and innovations in bio-catalysts. Furthermore, the rising number of designated laboratories which perform western blotting, polymerase chain reaction, and in in-vitro research studies is expected to drive market demand for proteinase K.
The increasing market demand for proteinase K for pre-treatment of COVID-19 infections is expected to drive product demand. Furthermore, the increasing demand for point of care diagnostics and the growing utility of proteinase K in PoC is expected to drive market demand. In addition, the use of proteinase K for in situ hybridization is likely to complement the proteinase K industry growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/proteinase-k-market/request-for-sample
Polaris Market Research has segmented the proteinase K market report on the basis of therapeutic area, by form, and geographic region:
Proteinase K, Therapeutic Area Outlook (Revenue - USD Million, 2016 - 2027)
Proteinase K, Form Outlook (Revenue - USD Million, 2016 - 2027)
Proteinase K Regional Outlook (Revenue - USD Million, 2016 - 2027)